Imipenem / Cilastatin 250 mg / 250 mg powder for solution for infusion

Licence status
Authorised: 18/12/2020
Active substances
Imipenem, Cilastatin
Dosage Form
Powder for solution for infusion
Licence number
PA2059/074/001
Licence holder
Fresenius Kabi Deutschland GmbH

Product documents

Licence information

ATC code
J01DH51 imipenem and enzyme inhibitor
Route of supply
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Marketing availability
Not marketed
Advertising conditions
Advertising to healthcare professionals only
Licence issued
18/12/2020

Stay updated: document advice

The information and documents on this page are subject to frequent updates. We recommend you do not retain saved or printed versions of them. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie